Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2016 by GlaxoSmithKline
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT02075593
First received: February 27, 2014
Last updated: July 5, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2021
  Estimated Primary Completion Date: February 2019 (Final data collection date for primary outcome measure)